Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea

ConditionDysmenorrhea

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorOsmaniye Korkut Ata University

About this trial

The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Pain and Menstrual Symptoms in Primary Dysmenorrhea

This study aims to investigate the effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in managing pain and alleviating menstrual symptoms in individuals with primary dysmenorrhea. Primary dysmenorrhea is characterized by severe menstrual pain and accompanying symptoms that negatively impact the quality of life and daily functioning. TENS, a non-invasive and drug-free method, is applied to relieve pain by stimulating nerves through electrical impulses. This research evaluates the impact of TENS on both the intensity of menstrual pain and associated symptoms, offering insights into its potential as an alternative or complementary therapeutic approach.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 and above

Have regular menstrual cycles (lasting 3 to 8 days, with a menstrual cycle range of 21 to 35 days)

Have dysmenorrhea pain severity rated 4 or higher on the Visual Analog Scale (VAS)

Disqualifiers

Secondary dysmenorrhea

Using oral contraceptives

Having impaired tissue integrity in the abdominal area

Having previous experience with TENS

Trial design

Design model

Parallel

Treatments tested in this trial

Transkutanöz Elektriksel Sinir Stimülasyonu - TENS
Other intervention
Transcutaneous Electrical Nerve Stimulation (TENS) has gained popularity in recent years as a non-invasive method for pain management. TENS works by modulating nerve stimulation through low-frequency electrical currents applied to the skin, reducing pain perception. Its potential effectiveness in alleviating menstrual pain has drawn increasing attention as an alternative treatment option

Treatment groups

93 Participants

are divided into 3 treatment groups

Group A: The group receiving the TENS treatmentExperimental treatment 1 intervention

Group B: Placebo ComparatorPlacebo comparator 1 intervention

Group C: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

Transcutaneous Electrical Nerve Stimulation

Transcutaneous Electrical Nerve Stimulation (TENS) is effective in pain management in women with primary dysmenorrhea. The Visual Analog Scale is a scale where the patient can mark their own pain on a ruler that can be used horizontally or vertically, where the pain is evaluated between 0-10. VCS is used to evaluate both the severity of pain and the effectiveness of the treatment/intervention on pain in various populations. An increase in the score indicates an increase in pain.

Time frame

3 months

Secondary outcomes

Transcutaneous Electrical Nerve Stimulation (TENS) is effective in managing menstrual symptoms in women with primary dysmenorrhea.

Transcutaneous Electrical Nerve Stimulation (TENS) is effective in managing menstrual symptoms in women with primary dysmenorrhea.A scale was developed by Taylor in 1979 to assess the symptoms and intensity of symptoms that occur during menstruation. The Turkish validity and reliability of the scale was performed by Oskay et al. in 2008. The scale, which contains seventeen items, has no sub-dimensions with each symptom being scored between 0 and 5. An increase in score indicates an increase in the intensity of the symptoms

Time frame

3 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Osmaniye Korkut Ata University

Lead sponsor

Source ClinicalTrials.gov

Apply now